Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Minerva Neurosciences Inc (NERV)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Minerva Neurosciences's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
0.372 -0.019    -4.86%
20/05 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
ISIN:  US6033801068 
CUSIP:  603380106
  • Volume: 52,314
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.350 - 0.389
Minerva Neurosciences 0.372 -0.019 -4.86%

NERV Financial Summary

 
A brief financial summary of Minerva Neurosciences Inc as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

For the three months ended 31 March 2022, Minerva Neurosciences Inc revenues was not reported. Net loss increased 11% to $9.8M. Higher net loss reflects Research and development - Balancing increase of 71% to $4.5M (expense), Non-cash interest expense for the sale increase of 37% to $1.8M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$0.21 to -$0.23.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

NERV Income Statement

Gross margin TTM -
Operating margin TTM -
Net Profit margin TTM -
Return on Investment TTM -57.85%
 Total Revenue  Net Income
Period Ending: Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Total Revenue 0 0 0 0
Gross Profit
Operating Income -7.99 -21.38 -7.52 -8.96
Net Income -9.76 -21.31 -9.21 -10.59

NERV Balance Sheet

Quick Ratio MRQ -
Current Ratio MRQ 17.15
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Total Assets 70.62 77.12 97.56 105.32
Total Liabilities 71.35 69.15 69.48 69.16
Total Equity -0.74 7.98 28.08 36.17

NERV Cash Flow Statement

Cash Flow/Share TTM -1.19
Revenue/Share TTM 0
Operating Cash Flow  -178.77%
 Cash  Net Change in Cash
Period Ending: Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Period Length: 3 Months 12 Months 9 Months 6 Months
Cash From Operating Activities -5.81 -24.6 -19.77 -11.14
Cash From Investing Activities 0 0 0 0
Cash From Financing Activities 0 60 60 60
Net Change in Cash -5.81 35.4 40.23 48.86
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

NERV Comments

Write your thoughts about Minerva Neurosciences Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Eren Eren
Eren Eren Dec 17, 2021 2:23AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Cash+equite above 90 million. This must be at least 2$
Reply
0 0
Report
José Poço
José Poço Jul 12, 2021 12:24PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What is happening?? Why is it falling????
Reply
0 0
Report
Victoria Monserrat
Victoria Monserrat May 13, 2021 1:05PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
lets go back to 4
Reply
2 0
Report
Yazeed AlKatteb
Yazeed AlKatteb Nov 23, 2020 12:25PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Will hit 4.40 with vaccine FDA approval
Reply
3 0
Report
Tariq AlZadjali
Tariq AlZadjali Nov 23, 2020 12:25PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
based on?
Reply
0 0
Report
Chinonso Vivian
Chinonso Vivian Jun 24, 2020 1:14AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I have been following this stock since it crashed, and today I have confirmed that it rise up again in no distance time.so buy now and make a lot of money. NERV is a high volatile stock and it is for the high dreamers.Now it is down just whatch out how it will sky rocket very soon.
Reply
7 4
Report
Franklyn Michaels
Franklyn Michaels Jun 24, 2020 1:14AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Do you have shares from this company Nne?
Reply
0 0
Report
Sdp Sam
Sdp Sam Jun 11, 2020 12:51PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
No comments on this stock for the past one week... Any hope for uptrend and target 4 at least?
Reply
2 0
Report
Afnan Benz
Afnan Benz Jun 11, 2020 12:51PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
wait for a couple of weeks it will come back up
Reply
1 0
Report
Assi Kissos
Assi Kissos Jun 05, 2020 1:56PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Hearing JMP Securities is Reinstating its Market Outperform Rating on Minerva Neurosciences with a $9 Price Target
Reply
4 0
Report
Shali Mehrez
Shali Mehrez Jun 05, 2020 1:54PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
in the next our it going to ******up
Reply
0 0
Report
Vibhas Bharti
Vibhas Bharti Jun 04, 2020 9:33PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What could be the status tomorrow? Bfre and after CC? Good to sell out?
Reply
0 2
Report
Petr Hasil
Petr Hasil May 29, 2020 3:57PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Do you thinkg it this will go up?
Reply
1 2
Report
Rashad Ahmadov
Rashad Ahmadov May 29, 2020 3:57PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
6-6.5
Reply
0 0
Report
Petr Hasil
Petr Hasil May 29, 2020 3:57PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Rashad Ahmadov I think this down was for this time but in future could be going up, there is to much people who have there miney on this stock for this price is not good for them a tehy will try to UP
Reply
1 0
Report
Drew BankedIt
Drew BankedIt May 29, 2020 3:57PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Rashad Ahmadov easy
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email